May 09, 2022 / 09:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to FibroGen's First Quarter 2022 Earnings Conference Call. (Operator Instructions)
Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your first speaker for today, Michael Tung. Thank you. Please go ahead, sir.
Michael Tung - FibroGen, Inc. - IR Executive
Thank you, RJ, and good afternoon, everyone. I'm Michael Tung, Vice President of Corporate Strategy and Investor Relations at FibroGen. Joining me on today's call are Enrique Conterno, our Chief Executive Officer; Dr. Mark Eisner, our Chief Medical Officer; Juan Graham, our Chief Financial Officer; Dr. John Hunter, our Chief Scientific Officer; Thane Wettig, our Chief Commercial Officer; and Chris Chung, our Senior Vice President of China Operations.
The format for today's call includes prepared remarks from Enrique and Juan, after which we will open up the call for Q&A.
I would like to remind you that remarks made on today's
Q1 2022 FibroGen Inc Earnings Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers